Patricia B. Williams

Web-based sharing of cutting-edge teaching strategies

Claire M. Lathers, Gilbert J. Burckart, Patricia B. Williams, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Continuing medical education: A vision of excellence

Patricia B. Williams, L. Tillack, L. Vogel, 1987 .

Comparison of Topical and Intravenous Administration of WIN 55-212-2 in Normotensive Rabbits

R. Allen, J. Sheppard, K. Pratap, 2008, Current eye research.

Omalizumab: a future innovation for treatment of severe ocular allergy?

Patricia B. Williams, John D Sheppard Jr, 2005, Expert opinion on biological therapy.

Cyclosporin as an Adjunct to Glaucoma Filtration Surgery

R. Allen, F. Lattanzio, Patricia B. Williams, 2005, Journal of glaucoma.

Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model.

J. Sheppard, F. Lattanzio, Patricia B. Williams, 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Confocal Microscopy Used as the Definitive, Early Diagnostic Method in Chandler Syndrome

R. Allen, J. Sheppard, F. Lattanzio, 2005, Cornea.

Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated.

G. Laurie, J. Sheppard, F. Lattanzio, 2011, Investigative ophthalmology & visual science.

Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.

J. Sheppard, F. Lattanzio, Patricia B. Williams, 2006, American journal of ophthalmology.

Lacritin and other new proteins of the lacrimal functional unit.

G. Laurie, Patricia B. Williams, Roy Karnati, 2009, Experimental eye research.

Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

R. Allen, A. Lichtman, F. Lattanzio, 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study

P. Meybohm, D. D. de Lange, R. Fumagalli, 2020, Annals of Intensive Care.

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis

J. Sheppard, Patricia B. Williams, Elizabeth Crandall, 2010, Clinical ophthalmology.